Investor Room
Welcome to Verv’s Investor Room. Here you’ll find comprehensive information to help you make an informed decision about investing with us. Read through the details and reach out to us with any questions!
Company Overview
At Verv, we’re cracking the code on making home health testing simple and accessible. Our devices are designed to cater to your health needs without requiring technical expertise or constant guidance. Verv products are intended to empower users with reliable health data, enabling informed decisions about your well-being.
With our devices and companion tests, you can trend, track, and monitor your health markers, and even share the data with your healthcare provider for a collaborative approach to your health.
With Verv, you’re not just monitoring your health; you’re taking control of it. No more guesswork, no more hassle—just smart, accurate health data that helps you live your optimal life.
Milestones and Achievements
2012
- Founding of Verv Technologies by Jeff Sutton, Hermann Falter, Ph.D, Angelo Muzzuchin, Ph.D, and Mike Staffen
2020
- July 1: International Patent Filing Date for Blood Separation and Analysis Device and Methods (PCT/CA2020/050013 [EN] & PCT/CA2020/050014 [FR])
- Nov. 18: $250,000 seed from Northern Ontario Heritage Fund and The Sudbury Catalyst Fund
2021
- Sept. 3: $500,000 grant from Northern Ontario Heritage Fund
- Oct. 29: $140,000 grant from National Research Council of Canada Industrial Research Assistance Program
2022
- July 21: $3.8M seed from Randox
2024
- Jan. 30: $100,000 from CAMEDA to accelerate commercial readiness of low-cost, high-quality blood analyzer
- Feb. 13: Over $1.3 million from the Northern Ontario Heritage Fund Corporation
- April 1: $52,000 grant from National Research Council of Canada Industrial Research Assistance Program
- September 1: Completion of the Vi analyzer - alpha prototype
Management Team
Supported by an advisory group of clinicians, lab experts, c-suite strategics, regulatories, and device partners.
